APAM 2025

118TH ANNUAL MEETING

3-4 April 2025

Royal College of Physicians

11 St Andrew’s Place, London NW1 4LE

X-twitter Linkedin Envelope Youtube Users

Welcome to APAM 2025 - What Awaits?

APAM 2025, the 118th Annual Meeting of the AoPGBI, will take place on 3–4 April 2025 at the Royal College of Physicians in London. This prestigious event will bring together leading clinicians, researchers, and healthcare professionals. It is a unique opportunity to collaborate, share insights, and advance groundbreaking research.

Panel discussion on the 'Challenges and opportunities for clinical academics in interdisciplinary translational research'

Professor Waljit Dhillo
  Professor in Endocrinology & Metabolism, Consultant Endocrinologist and an NIHR Senior Investigator
Dr Emily Watts
Wellcome Trust Clinical Research Career Development Fellow, University of Edinburgh
Professor Patrick F. Chinnery
Professor Patrick F. Chinnery
Executive Chair of the Medical Research Council
Professor Lucy Chappell
Professor Lucy Chappell
  Chief Scientific Adviser, Department of Health and Social Care (DHSC) Chief Executive Officer, National Institute for Health and Care Research (NIHR)
Professor Sir Stephen H. Powis
Professor Sir Stephen H. Powis
National Medical Director of NHS England
Professor Andrew Morris
President of the Academy of Medical Sciences, Director, Health Data Research UK

Scientific Symposia

  • Translating Big Data and AI
  • Health and a Changing Environment 
  • Changing Paradigms with Emerging Therapeutics
  • The Open Theme that will showcase quality and breadth of translational research outside of these areas. 

Keynote Speakers

• Professor Sir Douglas Turnbull (Newcastle University, Emeritus Professor of Neurology)

• Professor Nichola Cooper (Imperial College London, Professor of Immune Haematology and Honorary Consultant Haematologist)

• Professor Julian Knight (University of Oxford, Professor of Genomic Medicine

• Professor Mihaela van der Schaar (University of Cambridge, Chair in Machine Learning, Artificial Intelligence and Medicine)

• Professor Frank Kelly (Imperial College London, Battcock Chair in Community Health and Policy)

• Professor Lea Berrang Ford (University of Leeds, Priestley Chair in Climate and Health)

• Professor Andrew Baker (University of Edinburgh, Head of Centre for Cardiovascular Science)

• Dr Susan Galbraith, (AstraZeneca, EVP Oncology Haematology R&D)

ECR Workshop

A rare platform for early-career professionals to:

• Present research to a multispecialty audience of esteemed experts.

• Engage in meaningful dialogue leading to interdisciplinary collaborations and cross fertilisation of innovative research.

• Seek personalised guidance from leaders in and beyond your own fields.

Whether you aim to refine your research, gain valuable feedback, or network with respected leaders, these workshops are designed to empower the next generation of clinical innovators.

Join Us in London

We look forward to welcoming you all to London for a vibrant meeting in April 2025.  It is a particular pleasure to be welcoming you on behalf of the society founded by Sir William Osler.  As many of you will know, I have worked on ‘Morbus Osler’ (a.k.a. HHT) for more than 30 years.  Osler would be amazed at how far we have come in understanding the perversion of cell life that underlies disease, and would not recognise the topics of our Meeting Symposia, but would agree with our principles:

“Scientific discovery precedes good medical practice”
William Osler. Johns Hopkins Hosp Bull 1913:24;167-71

Meeting foci will include, as Osler advised, addressing individuality and variability alongside the novel insights into the ‘special features of disease’. We are eager to enhance our planned programme with your Abstract submissions in specific and open themes. 

Those accepted for Oral presentations will be embedded within the core Symposia, while those accepted for Poster presentation will be displayed in the iconic Dorchester Library, where presenters will have maximal exposure to peers and senior academic figures.

We trust you will be able to participate in this unique translational medicine event addressing the heart of improved medical care through scientific breakthroughs – so see you in London! 

The Royal College of Physicians, located at 11 St Andrew’s Place, London NW1 4LE, provides an iconic and inspiring setting for this annual meeting. Additionally, the venue offers state-of-the-art facilities that support dynamic presentations, discussions, and networking opportunities.

Claire L. Shovlin
Claire L. Shovlin
MB BChir, MA, PhD, FRCP, FAoP President-Elect, Association of Physicians of Great Britain and Ireland, Professor of Practice (Clinical and Molecular Medicine), Imperial College London
Abstract Submissions Closed
Registration Closed

Save APAM 2025 Date to your Calendar

Apple Google Office 365 Outlook Outlook.com Yahoo

Subscribe now to stay updated on the latest news and developments for APAM 2025!

Click here to subscribe
Dr Emily Watts APAM 2025

Dr Emily Watts

Wellcome Trust Clinical Research Career Development Fellow, University of Edinburgh

I am a respiratory physician and Wellcome Trust Clinical Research Career development fellow based in Edinburgh. My research interests are in understanding the molecular mechanisms which underpin neutrophilic inflammatory lung disease. Using air pollution as a model of inflammation my fellowship is focused on how neutrophils sense and respond to inflammatory and metabolic cues in the environment and how this drives neutrophil synthetic and inflammatory capacity.

Professor Sir Doug Turnbull

Emeritus Professor of Neurology Newcastle University

Sir Doug Turnbull is Emeritus Professor of Neurology, Newcastle University (UK). Professor Turnbull was Director of the Wellcome Centre for Mitochondrial Research and Director of the MRC Centre for Ageing and Vitality. He was the clinical lead for the NHS Highly Specialised Service for Rare Mitochondrial Diseases of Adults and Children.

Professor Turnbull’s research focused on understanding the role of mitochondria in health and disease. This has led to a new understanding of the importance and complexity of mitochondrial DNA disease, the development of a novel method to prevent the transmission of mitochondrial DNA disease (mitochondrial donation).

Mala Maini

Professor Mala Maini

Professor of Viral Immunology, University College London

Mala Maini is a Professor of Viral Immunology in the Institute of Immunity and Transplantation, Division of Infection and Immunity at UCL, London and an Honorary Consultant Physician in the viral hepatitis clinic. Her lab studies adaptive immunity to hepatitis B, liver cancer and SARS-CoV-2 to inform the development of immunotherapies and vaccines for these major causes of morbidity and mortality. Through access to well-characterised patient cohorts, human tissue samples and models, their studies provide insights into beneficial and dysfunctional T and B cell responses. The lab is particularly interested in dissecting and harnessing tissue-resident immunity for frontline sentinel surveillance of viruses and cancer.  Mala enjoys mentoring and supporting her lab members to obtain fellowships and develop their careers. Work in the Maini lab is funded by Wellcome (including Mala’s Investigator Award), UKRI, Cancer Research UK, ERC Horizon 2020 and the Royal Free Charity.
 

Professor Helen McShane

Professor of Vaccinology, University of Oxford

Helen McShane FRCP, PhD, FMedSci is Director, NIHR Oxford Biomedical Research Centre; Professor of Vaccinology, University of Oxford; Deputy Head, Medical Sciences Division and an Honorary Consultant Physician in Infectious Diseases.
Since 2001, Helen has lead the TB vaccine research group at the University of Oxford, and has expertise in vaccine design through to phase IIb efficacy testing. She led the development of the first candidate TB vaccine to enter efficacy testing, and now works on alternate routes of delivery and the development of controlled human infection models for TB and SARS CoV2.

Prof. Sarah Walmsley

AoPGBI Executive Committee Member and Professor of Respiratory Medicine at the University of Edinburgh

I am a Professor of Respiratory Medicine, University of Edinburgh, Honorary Consultant Physician, NHS Lothian and Co-Director of the Edinburgh Clinical Academic Training Scheme.  I undertook my medical training at the University of Edinburgh graduating in 1997, and an MRC training fellowship at the University of Cambridge with award of my PhD in 2004.  My specialist training in Respiratory Medicine was in Sheffield, where I also held a Welcome Intermediate Fellowship, prior to my move to Edinburgh as a Welcome Senior Clinical Fellow.  During this time, I had two periods of maternity leave.  I am currently based in the Centre for Inflammation Research in the Institute for Regeneration and Repair in Edinburgh.  My work is focused on understanding how local oxygen and nutrient availability in the inflamed environment can reprogram neutrophil behaviour in both acute and chronic inflammatory lung disease states.

APAM 2025

Dr Shera Chok

GP, NHS
Founder and Chair, The Shuri Network
NED, London Ambulance Service NHS Trust
National Lead for Community Settings, NIHR

Shera Chok is a GP in the NHS and is the former Chief Medical Officer at NHS Digital. She is an experienced national clinical leader who has worked at Board and Director levels since 2000 and has led the redesign and implementation of new models of care, digital innovation, clinical governance, workforce and leadership development at national and local levels.
She started the award-winning national Shuri Network in 2019 as she is passionate about increasing diversity, innovation and safety and to encourage other women from minority ethnic groups to lead and engage with digital transformation.
She has been recognised as an AI Visionary by the Kent, Surrey and Sussex Health Innovation Network & Department of Health and Social Care in 2025 and won the Zenith Global Health Special Recognition Award in 2023. She was awarded the prestigious Richard von Weizsäcker Fellowship by the Robert Bosch Foundation in 2023 and won the HSJ Race Equality Award winner in 2021 with the Shuri Network.
She advised ministers as a member of the NHS Independent Reconfiguration Panel for seven years and worked at Barts Health, the largest acute hospital trust in the NHS as Director of Primary Care for six years, helping to improve patient pathways across organisational boundaries.
Shera has volunteered as a clinician in countries including Sudan, Laos, Indonesia and Greece with NGOs working in war and disaster zones and with displaced populations. She studied at the Institute of Healthcare Improvement, Kennedy School of Government and the Harvard School of Public Health on an NHS executive leadership programme. She has completed an M.B.A., M.A. in Inter-professional Education and a Nuffield Trust Fellowship on cross-organisational learning with Sunderland Athletic Football Club.

Helen Devine APAM 2025

Dr Helen Devine

Newcastle University, Clinical NUAcT Fellow and Honorary
Consultant Neurologist

Dr Helens Bio coming soon

Professor Patrick Chinnery

Executive Chair of the Medical Research Council

Patrick Chinnery is Professor of Neurology at the University of Cambridge and an Honorary Consultant Neurologist at Addenbrooke’s Hospital. He runs a combined clinical and laboratory research programme based in the MRC Mitochondrial Biology Unit and has been supported by Wellcome since 1995 including a Principal Research Fellowship. He is known for his expertise in rare inherited diseases that affect the nervous system. His lab has been studying the genetic basis of mitochondrial disorders for over two decades, harnessing the power of whole genome sequencing and developing new treatments through experimental medicine and early phase trials. He jointly chairs the NIHR BioResource for Translational Research in Common and Rare diseases, is Executive Chair of the UK Medical Research Council and life sciences lead for UK Research and Innovation.